|
SPORE in Lymphoma
|
3P50CA126752-03S1
|
$371,941
|
$148,776
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-07
|
$1,961,712
|
$1,961,712
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-03
|
$2,266,618
|
$906,647
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-04
|
$258,530
|
$258,530
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-02
|
$318,513
|
$318,513
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Infection and Inflammation in Adult Gliomas
|
5K07CA131505-02
|
$135,445
|
$135,445
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-10S1
|
$69,244
|
$69,244
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-10
|
$421,279
|
$421,279
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
|
1R01CA131354-01A1
|
$365,892
|
$365,892
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-22
|
$560,086
|
$560,086
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-09
|
$725,501
|
$725,501
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-14
|
$417,501
|
$417,501
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$1,404
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$1,998
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$97,309
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
5R01CA134051-02
|
$493,967
|
$493,967
|
MOORMANN, ANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Virotherapy for Neuroblastoma Stem Cells
|
5R21CA133663-02
|
$202,500
|
$202,500
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$999
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$39,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-26
|
$402,500
|
$161,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Herpesvirus-induced telomerase dysregulation and tumor formation
|
5R01CA127238-03
|
$228,684
|
$228,684
|
Jarosinski, Keith
|
CORNELL UNIVERSITY ITHACA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$350,667
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response
|
5R21CA132279-02
|
$370,980
|
$370,980
|
POSNER, MARSHALL
|
DANA-FARBER CANCER INSTITUTE
|
|
Immune surveillance in murine gammaherpesvirus infection
|
2R01CA103642-06A1
|
$432,673
|
$432,673
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
5T32CA009111-32
|
$318,974
|
$95,692
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs
|
1K99CA137860-01A1
|
$98,753
|
$98,753
|
Gottwein, Eva
|
DUKE UNIVERSITY
|
|
Targeting Translation Control in Malignant Glioma
|
5R01CA124756-03
|
$266,760
|
$93,366
|
GROMEIER, MATTHIAS
|
DUKE UNIVERSITY
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
1R01CA134844-01A2
|
$321,841
|
$321,841
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
5F31CA132560-02
|
$28,256
|
$28,256
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Control of Gammaherpesvirus Replication
|
2R01CA052004-20A2
|
$320,153
|
$320,153
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Regulation of EBV Transcription in Burkitt's Lymphoma
|
5R01CA058524-15
|
$272,412
|
$272,412
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Characterization of the gamma HV68 v-cyclin
|
5R01CA087650-08
|
$316,022
|
$316,022
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
HPV: Biology, Clinical Significance and Epidemiology
|
5P01CA042792-21
|
$2,414,027
|
$241,403
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
2P30CA015704-35
|
$10,977,925
|
$109,779
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S3
|
$249,999
|
$2,500
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S4
|
$85,601
|
$856
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S5
|
$100,000
|
$1,000
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-33
|
$301,898
|
$150,949
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-02
|
$506,412
|
$506,412
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Pathobiology of Cancer at the Host and Population Level
|
5T32CA009382-27
|
$316,315
|
$47,447
|
GLIMCHER, LAURIE
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
2R01CA098285-06A1
|
$487,828
|
$487,828
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
SPORE in Lymphoma
|
3P50CA096888-05S2
|
$304,005
|
$76,001
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-22
|
$188,913
|
$9,446
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of KSHV in AIDS Malignancies
|
5P01CA113239-04
|
$1,152,020
|
$1,152,020
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
EBV Genome Expression:Localization of Specific Functions
|
5R01CA030356-28
|
$330,440
|
$330,440
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-13
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of replication and latency EBV EBNAs
|
5R37CA042245-24
|
$367,373
|
$367,373
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Herpes - Other for this search: $57,349,764
|